Caxton Associates (New York)’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-17,892
Closed -$759K – 491
2024
Q1
$759K Sell
17,892
-16,017
-47% -$624K 0.04% 267
2023
Q4
$1.42M Buy
+33,909
New +$1.3M 0.07% 172
2023
Q2
– Sell
-8,756
Closed -$434K – 522
2023
Q1
$434K Buy
+8,756
New +$443K 0.07% 286
2022
Q4
– Sell
-25,429
Closed -$1.05M – 472
2022
Q3
$1.05M Sell
25,429
-12,418
-33% -$562K 0.14% 99
2022
Q2
$1.61M Buy
+37,847
New +$2.12M 0.16% 51
2018
Q1
– Sell
-8,000
Closed -$489K – 338
2017
Q4
$489K Hold
8,000
– – 0.02% 294
2017
Q3
$441K Buy
+8,000
New +$406K 0.02% 379
2017
Q2
– Sell
-70,000
Closed -$2.94M – 479
2017
Q1
$2.94M Sell
70,000
-130,000
-65% -$4.75M 0.01% 151
2016
Q4
$6.36M Buy
200,000
+60,000
+43% +$1.72M 0.29% 69
2016
Q3
$3.7M Buy
+140,000
New +$3.36M 0.13% 124
2015
Q2
– Sell
-229,600
Closed -$5.69M – 155
2015
Q1
$5.69M Buy
+229,600
New +$4.88M 0.24% 73
2014
Q4
– Sell
-100,000
Closed -$2.01M – 126
2014
Q3
$2.01M Buy
100,000
+14,000
+16% +$289K 0.07% 151
2014
Q2
$1.65M Buy
+86,000
New +$1.52M 0.09% 130

Other funds holding CGNX

Caxton Associates (New York)'s CGNX Position: Q2 2024 in Review

Caxton Associates (New York) sold out of Cognex (CGNX) in Q2 2024, closing a stake of 17,892 shares — an estimated $759K sold.

Caxton Associates (New York) first reported a position in CGNX in Q2 2014 and held it in 13 quarters. The position peaked at $6.36M in Q4 2016. 443 funds tracked by Wall St. Rank hold CGNX as of Q2 2024.

  • Caxton Associates (New York) reported no remaining Cognex position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 17,892 Cognex shares in Q2 2024, an estimated $759K.
  • Caxton Associates (New York) first reported a position in Cognex in Q2 2014 and held it in 13 quarters.
  • Caxton Associates (New York)'s Cognex position peaked at $6.36M in Q4 2016.
  • 443 funds tracked by Wall St. Rank held Cognex as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.